- •Foreword
- •Preface
- •Contents
- •1.1 Introduction
- •1.2 Method
- •1.2.1 Databases
- •1.2.2 Dates
- •1.2.3 Keywords
- •1.2.4 Criteria for Inclusion
- •1.2.5 Criteria for Exclusion
- •1.2.6 Selection of Papers
- •1.3 Results
- •1.3.1 Subspecialty
- •1.3.2 Type of Telemedicine
- •1.3.3 Study Design
- •1.3.4 Final Conclusions of Papers
- •1.4 Discussion
- •References
- •2.1 Introduction
- •2.2 The Need for Diabetic Retinopathy Screening Programs
- •2.4 Guidelines for Referring Patients
- •2.7 Program Models for Diabetic Retinopathy Screening
- •2.9 Program Personnel and Operations
- •2.9.1 Primary Care Providers
- •2.9.2 Photographers
- •2.9.3 Clinical Consultants
- •2.9.4 Administrators
- •2.9.5 A Note to CEOs, Operations Directors, and Clinic Managers
- •2.10 Policies and Procedures
- •2.10.1 Sample Protocol 1
- •2.10.1.1 Diabetic Retinopathy Screening Services
- •Policy
- •Background
- •Procedure
- •2.10.2 Sample Protocol 2
- •2.10.2.1 Pupil Dilation Before Diabetic Retinopathy Photography
- •Policy
- •Background
- •Procedure
- •2.10.3 Sample Protocol 3
- •2.10.3.1 Diabetic Retinopathy Photography Review
- •Policy
- •Background
- •Procedure
- •2.11 Technical Requirements
- •2.11.1 Connectivity
- •2.11.2 Resolution
- •2.11.3 Color
- •2.11.4 Stereopsis
- •2.11.5 Compression
- •2.11.6 Enhancement
- •2.11.7 Pupil Dilation
- •2.11.8 Early California Telemedicine Initiatives Diabetic Retinopathy Screening
- •2.11.9 The American Indian Diabetes Teleophthalmology Grant Program
- •2.11.10 Central Valley EyePACS Diabetic Retinopathy Screening Project
- •2.12.1 Diabetic Retinopathy
- •2.12.1.1 ADA Guidelines Terms
- •2.12.1.2 Vitrectomy
- •References
- •3: Stereopsis and Teleophthalmology
- •3.1 Introduction
- •3.2 History of Stereopsis and Stereopsis in Ophthalmology
- •3.3 Technology and Photography
- •3.3.3 Imaging Fields
- •3.3.4 Image Viewing Techniques
- •3.3.5 Image Compression
- •3.4 Stereoscopic Teleophthalmology Systems
- •3.4.1 University of Alberta
- •3.4.4 Joslin Vision Network
- •3.5 Conclusion
- •References
- •4.1 Introduction
- •4.2 Methods
- •4.2.1 Main Outcome Measures
- •4.3 Results
- •4.3.1 Retinal Video Recording Versus Retinal Still Photography
- •4.3.2 Video Compression Analysis
- •4.4 Discussion
- •References
- •5.1 Introduction
- •5.1.1 Automated, Remote Image Analysis of Retinal Diseases
- •5.1.2 Telehealth
- •5.2 Design Requirements
- •5.2.1 Telehealth Network Architecture
- •5.2.2 Work Flow
- •5.2.3 Performance Evaluation of the Network
- •5.3 Automated Image Analysis Overview
- •5.3.1 Quality Assessment Module
- •5.3.2 Vascular Tree Segmentation
- •5.3.3 Quality Evaluation
- •5.4 Anatomic Structure Segmentation
- •5.4.1 Optic Nerve Detection
- •5.4.2 Macula
- •5.4.3 Lesion Segmentation
- •5.4.4 Lesion Population Description
- •5.4.5 Image Query
- •5.5 Summary
- •References
- •6.1 Introduction
- •6.3 Optical Coherence Tomography to Detect Leakage
- •References
- •7.1 Introduction
- •7.2 Patients and Methods
- •7.2.1 Participants
- •7.2.2 Methods
- •7.2.3 Statistics
- •7.3 Results
- •7.3.1 Reliability of Image Evaluation
- •7.3.2 Prevalence of Glaucomatous Optic Nerve Atrophy
- •7.4 Discussion
- •7.5 Perspectives
- •References
- •8.1 Introduction
- •8.1.2 Homology Between Retinal and Systemic Microvasculature
- •8.1.3 Need for More Precise CVD Risk Prediction
- •8.2.1 Retinal Microvascular Signs
- •8.2.2 Retinal Vessel Biometry
- •8.2.3 Newer Retinal Imaging for Morphologic Features of Retinal Vasculature
- •8.3 Associations of Retinal Imaging and CVD Risk
- •8.3.1.1 Risk of Pre-clinical CVD
- •8.3.1.2 Risk of Stroke
- •8.3.1.3 Risk of Coronary Heart Disease
- •8.3.2.1 Risk of Hypertension
- •8.3.2.2 Risk of Stroke
- •8.3.2.3 Risk of Coronary Heart Disease
- •8.3.2.4 Risk of Peripheral Artery Disease
- •8.3.3 Newer Morphologic Features of Retinal Vasculature
- •8.4 Retinal Imaging and Its Potential as a Tool for CVD Risk Prediction
- •References
- •9.1 Alzheimer’s Disease
- •9.2 Treatments
- •9.3 Diagnosis
- •9.6 Conclusions
- •References
- •10.1 Introduction
- •10.1.1 Stroke
- •10.1.2 Heart Disease
- •10.1.3 Arteriovenous Ratio
- •10.2 Purpose
- •10.3 Method
- •10.3.1 Medical Approach
- •10.3.2 Technical Approach
- •10.3.3 Output of Medical Data
- •10.4 Patients
- •10.5 Results
- •10.5.1 Medical History
- •10.5.2 Telemedical Evaluation of Retinal Vessels
- •10.5.2.1 Prevalence of Retinal Microangiopathy
- •10.5.2.2 Arteriovenous Ratio
- •10.5.2.3 PROCAM-Index
- •10.6 Discussion and Perceptive
- •10.6.1 Estimation of “Stroke Risk” Estimated by the Stage of Retinal Microangiopathy
- •References
- •11.1 Introduction
- •11.2 System Requirements
- •11.3 Fundus Camera
- •11.4 Imaging Procedure
- •11.4.1 Reading Center Procedure
- •11.5 Detection of Macular Edema
- •11.6 Implementation
- •11.7 Unreadable Images
- •11.7.1 Impact on Overall Diabetic Retinopathy Assessment Rates
- •11.7.2 Compliance with Recommendations
- •11.7.3 Challenges
- •11.7.4 Summary
- •References
- •12.1 Screening
- •12.2 Background
- •12.3 Historical Perspective in England
- •12.4 Methodology
- •12.4.1 The Aim of the Programme
- •12.5 Systematic DR Screening
- •12.6 Cameras for Use in the English Screening Programme
- •12.7 Software for Use in the English Screening Programme
- •12.9 Implementation in England
- •12.11 Quality Assurance
- •12.12 The Development of External Quality Assurance in the English Screening Programme
- •12.13 Information Technology (IT) Developments for the English Screening Programme
- •12.14 Dataset Development
- •12.15 The Development of External Quality Assurance Test Set for the English Screening Programme
- •12.16 Failsafe
- •12.17 The Epidemic of Diabetes
- •References
- •13.1 Introduction
- •13.2 Burden of Diabetes and Diabetic Retinopathy in India
- •13.3 Diabetic Retinopathy Screening Models
- •13.4 Need for Telescreening
- •13.5 Guidelines for Telescreening
- •13.6 ATA Categories of DR Telescreening Validation
- •13.7 Yield of Diabetic Retinopathy in a Telescreening Model
- •13.8 How Are Images Transferred
- •13.10 How Many Fields Are Enough for Diabetic Retinopathy Screening
- •13.11 Is Mydriasis Needed While Using Nonmydriatic Camera?
- •13.12 Validation Studies on Telescreening
- •13.12.1 Accuracy of Telescreening
- •13.12.2 Patient Satisfaction in Telescreening
- •13.12.3 Cost Effectivity
- •13.12.4 Telescreening for Diabetic Retinopathy: Our Experience
- •13.13 Future of Diabetic Retinopathy Screening
- •References
- •14.1 Introduction
- •14.2 Methods
- •14.3 Discussion
- •14.4 Conclusion
- •References
- •15.1 Introduction
- •15.1.1 Description of the EADRSI
- •15.5 State Support of Screening in the Safety Net
- •15.7 Screening Economics for Providers
- •15.8 Patient Sensitivity to Fees
- •15.9 Conclusion
- •References
- •16.1 Introduction
- •16.2 Setting Up the New Screening Model
- •16.2.1 Phase 1: Training
- •16.2.2 Phase 2: Evaluation of Agreement
- •16.2.3 Phase 3: Implementation of the Screening Model
- •16.3 Technologic Requirements
- •16.3.1 Data Management
- •16.3.2 Data Models
- •16.3.2.1 Data Scheme for Patient-Related Information
- •16.3.2.2 Data Scheme for Images
- •Fundus Camera VISUCAM Pro NM
- •PACS Server
- •ClearCanvas DICOM Visualizer
- •16.4 Results
- •16.4.1 Phase 2: Agreement Evaluation
- •16.4.2 Phase 3: Implementation of the Screening Model
- •16.5 Discussion
- •16.5.1 Evaluation of the Screening Model
- •16.5.2 Prevalence of DR
- •16.5.3 Quality Evaluation
- •16.6 Conclusion
- •References
- •17.1.3 Examination and Treatment
- •17.1.4 Limitations of Current Care
- •17.2 Telemedicine and ROP
- •17.2.2 Accuracy and Reliability of Telemedicine for ROP Diagnosis
- •17.2.3 Operational ROP Telemedicine Systems
- •17.2.4 Potential Barriers
- •17.3 Closing Remarks
- •17.3.1 Future Directions
- •References
- •18.1 Introduction
- •18.2 Neonatal Stress and Pain
- •18.3 ROP Screening Technique
- •18.4 Effect of Different Examination Techniques on Stress
- •18.5 Future of Retinal Imaging in Babies
- •References
- •19.1 Introduction
- •19.2 History of the Program
- •19.3 Telehealth Technologies
- •19.4 Impact of the Program
- •Selected References
- •Preamble
- •Introduction
- •Background
- •The Diabetic Retinopathy Study (DRS)
- •Mission
- •Vision
- •Goals
- •Guiding Principles
- •Ethics
- •Clinical Validation
- •Category 1
- •Category 2
- •Category 3
- •Category 4
- •Communication
- •Medical Care Supervision
- •Patient Care Coordinator
- •Image Acquisition
- •Image Review and Evaluation
- •Information Systems
- •Interoperability
- •Image Acquisition
- •Compression
- •Data Communication and Transmission
- •Computer Display
- •Archiving and Retrieval
- •Security
- •Reliability and Redundancy
- •Documentation
- •Image Analysis
- •Legal Requirements
- •Facility Accreditation
- •Privileging and Credentialing
- •Stark Act and Self-referrals
- •State Medical Practice Acts/Licensure
- •Tort Liability
- •Duty
- •Standards of Care
- •Consent
- •Quality Control
- •Operations
- •Customer Support
- •Originating Site
- •Transmission
- •Distant Site
- •Financial Factors
- •Reimbursement
- •Grants
- •Federal Programs
- •Other Financial Factors
- •Equipment Cost
- •Summary
- •Abbreviations
- •Appendices
- •Appendix A: Interoperability
- •Appendix B: DICOM Metadata
- •Appendix C: Computer-Aided Detection
- •Appendix D: Health Insurance Portability and Accountability Act (HIPAA)
- •Appendix F: Quality Control
- •Appendix H: Customer Support
- •Level 1
- •Level 2
- •Level 3
- •Appendix I: Reimbursement
- •Medicare
- •Medicaid
- •Commercial Insurance Carrier Reimbursement
- •Other Financial Factors
- •Disease Prevention
- •Resource Utilization
- •American Telemedicine Association’s Telehealth Practice Recommendations for Diabetic Retinopathy
- •Conclusion
- •References
- •Contributors
- •Second Edition
- •First Edition
- •Index
86 |
R. Kawasaki and T.Y. Wong |
|
|
length to diameter ratio was associated with increased stroke mortality [59]. Chapman et al. reported that ‘optimality’ at arterial branching point in retinal vasculature is affected in men with PVD; the junction exponent, an index of efficiency in haemodynamic, was also deviated from the optimum value. They speculated that this might reflect abnormality of the vascular endothelium because endothelial function plays an important role in maintaining network coordination of branch diameters [93].
8.4Retinal Imaging and Its Potential as a Tool for CVD Risk Prediction
As illustrated in this chapter, the association of retinal signs and CVD has been studied in numerous epidemiological and clinical research settings. Studies have demonstrated prospective associations of retinal signs with future development of CVD. Despite these strong and consistent associations, more translational work is needed to fill the gap between research evidence and clinical practice. For retinal imaging to be clinically useful as a tool for CVD risk prediction, the technique should demonstrate additional prognostic information for conventional CVD risk prediction models such as the Framingham risk score. For example, although retinal vessel calibre had a significant association with increased CHD risk independent of traditional risk factors, the magnitude of information by adding retinal vascular calibre onto the traditional risk prediction model of the Framingham risk score was considered unlikely to change clinical management of patients [88].
Nevertheless, advancements in retinal vascular imaging technologies in the last few decades have provided a non-invasive direct window to quantify subtle morphological features in retinal vasculature. As current grading for retinal images is still highly dependent on human graders, automated assessment to support human grader will contribute to increased cost-effectiveness of retinal screening in CVD risk prediction. To maximize the potential of retinal imaging, advancements in
digital imaging in noise reduction, retinal vessel identification, retinal pathology detection and quantification of vessel geometry or morphology will be critical. Also, the cost-effectiveness of retinal vascular imaging must be evaluated, especially as the measurement of traditional risk factors (e.g. blood pressure, serum cholesterol) is relatively inexpensive and is widely available. Such issues need to be resolved before retinal imaging could be accepted as a clinical tool of CVD risk prediction. To translate these research findings for community benefits, telemedicine or telescreening will be an ideal platform for retinal imaging to achieve this potential.
References
1. Yogesan K, Constable IJ, Barry CJ, Eikelboom RH, McAllister IL, Tay-Kearney ML (2000) Telemedicine screening of diabetic retinopathy using a hand-held fundus camera. Telemed J 6(2):219–223
2. Aiello LM, Bursell SE, Cavallerano J, Gardner WK, Strong J (1998) Joslin Vision Network Validation Study: pilot image stabilization phase. J Am Optom Assoc 69(11):699–710
3. Lemmetty R, Makela K (2009) Mobile digital fundus screening of type 2 diabetes patients in the Finnish county of South-Ostrobothnia. J Telemed Telecare 15(2):68–72
4. Liesenfeld B, Kohner E, Piehlmeier W, Kluthe S, Aldington S, Porta M et al (2000) A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care 23(3):345–348 5. Bergua A, Mardin CY, Horn FK (2009) Teletransmission of stereoscopic images of the optic nerve head in glaucoma via Internet. Telemed J E Health
15(5):439–444
6. Beauregard D, Lewis J, Piccolo M, Bedell H (2000) Diagnosis of glaucoma using telemedicine–the effect of compression on the evaluation of optic nerve head cupdisc ratio. J Telemed Telecare 6(Suppl 1):S123–S125
7. Williams SL, Wang L, Kane SA, Lee TC, Weissgold DJ, Berrocal AM et al (2010) Telemedical diagnosis of retinopathy of prematurity: accuracy of expert vs. non-expert graders. Br J Ophthalmol 94(3):351–356, Epub 2009 Dec 2
8.Lorenz B, Spasovska K, Elflein H, Schneider N (2009) Wide-field digital imaging based telemedicine for
screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study. Graefes Arch Clin Exp Ophthalmol 247(9):1251–1262
9. Murakami Y, Silva RA, Jain A, Lad EM, Gandhi J, Moshfeghi DM (2010) Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP):
8 Retinal Vascular Imaging for Cardiovascular Risk Prediction |
87 |
|
|
24-month experience with telemedicine screening. Acta Ophthalmol 88(3):317–322, Epub 2009 Nov 20
10. Scott KE, Kim DY, Wang L, Kane SA, Coki O, Starren J et al (2008) Telemedical diagnosis of retinopathy of prematurity intraphysician agreement between ophthalmoscopic examination and image-based interpretation. Ophthalmology 115(7):1222–1228, e3
11. Keith NM, Wagener HP, Barker NW (1939) Some different types of essential hypertension: their course and prognosis. Am J Med Sci 197:332–343
12. Klein R, Klein BE, Moss SE (1992) Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15(12):1875–1891
13.Klein BEK (2004) Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes – Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 164(17):1917–1924
14.Fuller JH (2001) Risk factors for cardiovascular mortality and morbidity: the WHO multinational study of
vascular disease in diabetes. Diabetologia 44:S54–S64 15. Petitti DB, Bhatt H (1995) Retinopathy as a risk factor for nonembolic stroke in diabetic subjects. Stroke
26(4):593–596
16. Cheung N, Rogers S, Couper DJ, Klein R, Sharrett AR, Wong TY (2007) Is diabetic retinopathy an independent risk factor for ischemic stroke? Stroke 38(2):398–401, Epub 2006 Dec
17.Juutilainen A (2007) Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 30(2):292–299
18.Soedamah-Muthu SS (2004) Risk factors for coronary heart disease in type 1 diabetic patients in Europe – The EURODIAB Prospective Complications Study. Diabetes Care 27(2):530–537
19.Cheung N (2008) Diabetic retinopathy and risk of
heart failure. J Am Coll Cardiol 51(16):1573–1578 20. Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett
AR, Wong TY (2007) Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities study. Diabetes Care 30(7):1742– 1746, Epub 2007 Mar
21.Klein R, Klein BE, Moss SE, Cruickshanks KJ (1999) Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 117(11):1487–1495
22.Cusick M (2005) Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes – Early Treatment Diabetic Retinopathy Study Report no. 27. Diabetes Care 28(3):617–625
23.van Hecke MV (2005) Diabetic retinopathy is associated with mortality and cardiovascular disease incidence – The EURODIAB prospective complications study. Diabetes Care 28(6):1383–1389
24.Walters DP, Gatling W, Houston AC, Mullee MA, Julious SA, Hill RD (1994) Mortality in diabetic subjects: an eleven-year follow-up of a community-based population. Diabet Med 11(10):968–973
25.Grauslund J (2008) Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark. Diabetologia 51(4):583–588
26.Weis U (2001) Long-term predictors of coronary artery disease and mortality in type 1 diabetes. Q J Med 94(11):623–630
27.Hanis CL, Chu HH, Lawson K, Hewett-Emmett D, Barton SA, Schull WJ et al (1993) Mortality of Mexican Americans with NIDDM Retinopathy and other predictors in Starr County, Texas. Diabetes Care 16(1):82–89
28. Goto I, Katsuki S, Ikui H, Kimoto K, Mimatsu T (1975) Pathological studies on the intracerebral and retinal arteries in cerebrovascular and noncerebrovascular diseases. Stroke 6(3):263–269
29. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Matsuda M, Hamashima Y et al (1987) Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 75(6):1130–1139
30.Schneider R, Rademacher M, Wolf S (1993) Lacunar infarcts and white matter attenuation. Ophthalmologic and microcirculatory aspects of the pathophysiology. Stroke 24(12):1874–1879
31.Korber N, Schneider R, Brockmann M (1986) Circulatory parameters of the retina in patients with lacunar stroke. J Neurol 233(1):30–33
32. Lindley RI, Wang JJ, Wong MC, Mitchell P, Liew G, Hand P et al (2009) Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol 8(7):628–634
33. Kwa VI, van der Sande JJ, Stam J, Tijmes N, Vrooland JL (2002) Amsterdam Vascular Medicine G. Retinal arterial changes correlate with cerebral small-vessel disease. Neurology 59(10):1536–1540
34. Longstreth W Jr, Larsen EKM, Klein R, Wong TY, Sharrett AR, Lefkowitz D et al (2007) Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly: the Cardiovascular Health Study. Am J Epidemiol 165(1):78–84, Epub 2006 Oct
35.Cooper LS (2006) Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction – the atherosclerosis risk in communities study. Stroke
37(1):82–86
36. Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP et al (2002) Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288(1):67–74
37.Michelson EL, Morganroth J, Nichols CW, MacVaugh H 3rd (1979) Retinal arteriolar changes as an indicator of coronary artery disease. Arch Intern Med 139(10):1139–1141
38.Tedeschi-Reiner E, Strozzi M, Skoric B, Reiner Z (2005) Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease. Am J Cardiol 96(8):1107–1109
39.Gaziano TA (2007) Reducing the growing burden of cardiovascular disease in the developing world. Health Aff (Millwood) 26(1):13–24
40.D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM et al (2008) General cardiovascularriskprofileforuseinprimarycare:theFramingham Heart Study. Circulation 117(6):743–753
88 |
R. Kawasaki and T.Y. Wong |
|
|
41. Brindle P, Beswick A, Fahey T, Ebrahim S (2006) Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 92(12):1752–1759
42.Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98(5 Suppl):786–806
43.Pirbhai A, Sheidow T, Hooper P (2005) Prospective evaluation of digital non-stereo color fundus photography as a screening tool in age-related macular degeneration. Am J Ophthalmol 139(3):455–461
44.Baker CF, Rudnisky CJ, Tennant MT, Sanghera P, Hinz BJ, De Leon AR et al (2004) JPEG compression of stereoscopic digital images for the diagnosis of dia-
betic retinopathy via teleophthalmology. Can J Ophthalmol 39(7):746–754
45. Perrier M, Boucher MC, Angioi K, Gresset JA, Olivier S (2003) Comparison of two, three and four 45 degrees image fields obtained with the Topcon CRW6 nonmydriatic camera for screening for diabetic retinopathy. Can J Ophthalmol 38(7):569–574
46. Rudnisky CJ, Tennant MT, Weis E, Ting A, Hinz BJ, Greve MD (2007) Web-based grading of compressed stereoscopic digital photography versus standard slide film photography for the diagnosis of diabetic retinopathy. Ophthalmology 114(9):1748–1754
47. Basu A, Kamal AD, Illahi W, Khan M, Stavrou P, Ryder RE (2003) Is digital image compression acceptable within diabetic retinopathy screening? Diabet Med 20(9):766–771
48. Sharp PF, Olson J, Strachan F, Hipwell J, Ludbrook A, O’Donnell M et al (2003) The value of digital imaging in diabetic retinopathy. Health Technol Assess 7(30):1–119
49.Parr JC, Spears GF (1974) Mathematic relationships between the width of a retinal artery and the widths of its branches. Am J Ophthalmol 77(4):478–483
50.Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS et al (1999) Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 106(12): 2269–2280
51.Parr JC, Spears GF (1974) General caliber of the retinal
arteries expressed as the equivalent width of the central retinal artery. Am J Ophthalmol 77(4):472–477
52. Couper DJ, Klein R, Hubbard LD, Wong TY, Sorlie PD, Cooper LS et al (2002) Reliability of retinal photography in the assessment of retinal microvascular characteristics: the Atherosclerosis Risk in Communities study. Am J Ophthalmol 133(1):78–88
53. Wong TY, Knudtson MD, Klein R, Klein BE, Meuer SM, Hubbard LD (2004) Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes,
and effect of refractive errors. Ophthalmology 111(6):1183–1190
54.Knudtson MD (2003) Revised formulas for summarizing retinal vessel diameters. Curr Eye Res 27(3):143–149
55.Patton N, Aslam TM, MacGillivray T, Deary IJ, Dhillon B, Eikelboom RH et al (2006) Retinal image analysis: concepts, applications and potential. Prog Retin Eye Res 25(1):99–127, Epub 2005 Sep
56. Rudnicka AR, Burk RO, Edgar DF, Fitzke FW (1998) Magnification characteristics of fundus imaging systems. Ophthalmology 105(12):2186–2192
57. Liew G, Wang JJ, Cheung N, Zhang YP, Hsu W, Lee ML et al (2008) The retinal vasculature as a fractal: methodology, reliability, and relationship to blood pressure. Ophthalmology 115(11):1951–1956
58. Cheung N, Donaghue KC, Liew G, Rogers SL, Wang JJ, Lim SW et al (2009) Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care 32(1):106–110
59.Witt N, Wong TY, Hughes AD, Chaturvedi N, Klein BE, Evans R et al (2006) Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension 47(5):975–981
60.Sherman TF (1981) On connecting large vessels to small. The meaning of Murray’s law. J Gen Physiol 78(4):431–453
61.Liew G, Wang JJ, Mitchell P, Wong TY (2008) Retinal vascular imaging: a New tool in microvascular disease research. Circ Cardiovasc Imaging 1(2):156–161
62. Klein R, Sharrett AR, Klein BEK, Moss SE, Folsom AR, Wong TY et al (2002) The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology 109(7):1225–1234
63. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD et al (2001) Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities study. Lancet 358(9288):1134–1140
64. Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR (2005) Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 65(7): 1005–1009
65. Duncan BB, Wong TY, Tyroler HA, Davis CE, Fuchs FD (2002) Hypertensive retinopathy and incident coronary heart disease in high risk men. Br J Ophthalmol 86(9):1002–1006
66. Hirai FE (2007) Retinopathy and survival in a population without diabetes the beaver dam eye study. Am J Epidemiol 166(6):724–730
67. Wong TY, Rosamond W, Chang PP, Couper DJ, Sharrett AR, Hubbard LD et al (2005) Retinopathy and risk of congestive heart failure. JAMA 293(1):63–69
68. Cheung N, Jie JW, Klein R, Couper DJ, Sharrett AR, Wong TY (2007) Diabetic retinopathy and the risk of coronary heart disease: the atherosclerosis risk in communities study. Diabetes Care 30(7):1742–1746
69. Klein R, Klein BE, Moss SE, Wang Q (1994) Hypertension and retinopathy, arteriolar narrowing,
8 Retinal Vascular Imaging for Cardiovascular Risk Prediction |
89 |
|
|
and arteriovenous nicking in a population. Arch Ophthalmol 112(1):92–98
70. Klein R, Klein BE, Moss SE (1997) The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 95:329–348; discussion 48–50
71.Wong TY, Mitchell P (2004) Hypertensive retinopathy. N Engl J Med 351(22):2310–2317
72.Tso MO, Jampol LM (1982) Pathophysiology of hypertensive retinopathy. Ophthalmology 89(10): 1132–1145
73.Walsh JB (1982) Hypertensive retinopathy. Description, classification, and prognosis. Ophthalmology 89(10):1127–1131
74.Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ, Nieto FJ et al (1999) Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities study. Am J Epidemiol 150(3):263–270
75. Wong TY, Klein R, Klein BE, Meuer SM, Hubbard LD (2003) Retinal vessel diameters and their associations with age and blood pressure. Invest Ophthalmol Vis Sci 44(11):4644–4650
76. Ikram MK, de Jong FJ, Vingerling JR, Witteman JC, Hofman A, Breteler MM et al (2004) Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 45(7):2129–2134
77.Leung H, Wang JJ, Rochtchina E, Tan AG, Wong TY, Klein R et al (2003) Relationships between age,
blood pressure, and retinal vessel diameters in an older population. Invest Ophthalmol Vis Sci 44(7): 2900–2904
78. Wong TY, Hubbard LD, Klein R, Marino EK, Kronmal R, Sharrett AR et al (2002) Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol 86(9): 1007–1013
79.Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Klein BE et al (2004) Retinal arteriolar diameter and risk for hypertension. Ann Intern Med 140(4):248–255
80. Smith W, Wang JJ, Wong TY, Rochtchina E, Klein R, Leeder SR et al (2004) Retinal arteriolar narrowing is associated with 5-year incident severe hypertension: the Blue Mountains Eye Study. Hypertension 44(4): 442–447
81.Wang JJ, Rochtchina E, Liew G, Tan AG, Wong TY, Leeder SR et al (2008) The long-term relation among retinal arteriolar narrowing, blood pressure, and incident
severe hypertension. Am J Epidemiol 168(1):80–88 82. Wong TY, Kamineni A, Klein R, Sharrett AR, Klein
BE, Siscovick DS et al (2006) Quantitative retinal venular caliber and risk of cardiovascular disease in
older persons: the cardiovascular health study. Arch Intern Med 166(21):2388–2394
83. Ikram MK, de Jong FJ, Bos MJ, Vingerling JR, Hofman A, Koudstaal PJ et al (2006) Retinal vessel diameters and risk of stroke: the Rotterdam Study. Neurology 66(9):1339–1343
84. Ikram MK, De Jong FJ, Van Dijk EJ, Prins ND, Hofman A, Breteler MM et al (2006) Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. Brain 129(Pt 1):182–188
85. Klein R, Klein BEK, Moss SE, Wong TY (2007) Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 114(10):1884–1892, Epub 2007 May
86. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE et al (2009) Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol 170(11):1323–1332
87. Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Tielsch JM et al (2002) Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities study. JAMA 287(9):1153–1159
88. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Sharrett AR et al (2008) Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] study). Am J Cardiol 102(1):58–63
89. Wang JJ, Liew G, Wong TY, Smith W, Klein R, Leeder SR et al (2006) Retinal vascular calibre and the risk of coronary heart disease-related death. Heart 92(11): 1583–1587
90. Wang JJ, Liew G, Klein R, Rochtchina E, Knudtson MD, Klein BE et al (2007) Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J 28(16): 1984–1992
91. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE et al (2009) Meta-analysis: retinal vessel caliber and risk for coronary heart disease. Ann Intern Med 151(6):404–413
92.Hughes AD, Martinez-Perez E, Jabbar AS, Hassan A, Witt NW, Mistry PD et al (2006) Quantification of topological changes in retinal vascular architecture in
essential and malignant hypertension. J Hypertens 24(5):889–894
93. Chapman N, Dell’omo G, Sartini MS, Witt N, Hughes A, Thom S et al (2002) Peripheral vascular disease is associated with abnormal arteriolar diameter relationships at bifurcations in the human retina. Clin Sci (Lond) 103(2):111–116
